13F-HR filed by Soleus Capital Management, L.P.
Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 92 holding rows worth $1,133,962,902.
- Accession
- 0001802630-24-000008
- Filer
- CIK 1802630
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 92 entries on the cover page, a total value of $1,133,962,902 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,133,962,902 with VALUE read as dollars as filed, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 3,645,562 | $64,854,548 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 7,548,000 | $60,534,960 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 141,499 | $45,074,506 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 2,055,916 | $42,906,967 | dollars as filed | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 7,293,728 | $39,677,880 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 4,947,738 | $33,694,096 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 856,178 | $33,228,268 | dollars as filed | |
| Surmodics Inc | 868873100 | Common Stock | 781,777 | $32,865,905 | dollars as filed | |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 11,518,954 | $32,253,071 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 1,276,190 | $28,969,513 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 694,069 | $24,368,763 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 3,305,815 | $23,934,101 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 126,000 | $23,138,640 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 376,321 | $22,266,914 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 123,450 | $22,217,297 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 4,210,537 | $22,147,425 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 533,015 | $22,045,500 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 1,211,187 | $19,839,243 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 408,373 | $19,663,160 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 137,700 | $19,645,659 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 4,051,996 | $18,720,222 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 853,628 | $18,583,482 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 2,433,168 | $18,394,750 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 769,263 | $17,977,676 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 71,700 | $17,423,100 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 826,500 | $16,968,045 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 44,356 | $16,573,619 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 415,000 | $15,977,500 | dollars as filed | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 2,365,648 | $15,731,559 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 185,250 | $13,988,228 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 719,000 | $13,984,550 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 424,585 | $13,404,148 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 171,788 | $13,031,838 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 1,152,000 | $12,499,200 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 799,546 | $10,370,112 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 2,239,006 | $10,165,087 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 221,600 | $10,127,120 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 586,499 | $9,530,609 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 170,741 | $9,423,196 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 6,111,964 | $9,351,305 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,049,895 | $9,008,099 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 309,500 | $8,901,220 | dollars as filed | |
| RIGEL PHARMACEUTICALS INC | 766559702 | COMMON STOCK | 1,043,697 | $8,579,189 | dollars as filed | |
| BAUSCH HEALTH COS INC COM | 071734107 | Stock | 1,206,000 | $8,405,820 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 7,293,007 | $8,095,238 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 647,982 | $7,827,623 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 800,000 | $7,544,000 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 399,430 | $7,509,284 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 509,000 | $7,156,540 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 201,000 | $7,093,290 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 587,098 | $7,039,305 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 102,472 | $6,865,624 | dollars as filed | |
| HIMS & HERS HEALTH INC | 433000106 | COM CL A | 333,000 | $6,723,270 | dollars as filed | |
| THERATECHNOLOGIES INC | 88338H704 | COM | 4,801,376 | $6,721,926 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 251,900 | $6,650,160 | dollars as filed | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 1,720,000 | $6,226,400 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 1,269,714 | $5,929,564 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 86,000 | $5,890,140 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 53,935 | $5,756,483 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 3,901,314 | $5,344,800 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 2,162,162 | $5,102,702 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,661,297 | $4,950,665 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 1,246,953 | $4,489,031 | dollars as filed | |
| IRADIMED CORP | 46266A109 | COMMON STOCK | 102,067 | $4,484,824 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 340,000 | $4,423,400 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 91,611 | $3,870,565 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 18,800 | $3,793,840 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 200,000 | $3,734,000 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 1,378,128 | $3,438,843 | dollars as filed | |
| CALCIMEDICA INC | 38942Q202 | COM NEW | 783,904 | $3,104,260 | dollars as filed | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 1,604,718 | $3,081,059 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 62,500 | $3,032,500 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 870,000 | $2,853,600 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 4,051,000 | $2,349,580 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 216,500 | $2,342,530 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 55,500 | $2,324,895 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 108,598 | $2,279,472 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 87,000 | $2,274,180 | dollars as filed | |
| CERVOMED INC | 15713L109 | COM | 126,614 | $2,167,632 | dollars as filed | |
| AVITA THERAPEUTICS, INC. | 05380C102 | COM | 267,000 | $2,114,640 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 108,900 | $1,865,457 | dollars as filed | |
| INHIBRX BIOSCIENCES INC | 45720N103 | COM | 88,470 | $1,253,620 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 163,000 | $1,152,410 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 147,246 | $1,010,108 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 15,000 | $681,600 | dollars as filed | |
| ORTHOFIX MED INC | 68752M108 | COM | 51,000 | $676,260 | dollars as filed | |
| MIMEDX GROUP INC | 602496101 | COM | 82,884 | $574,386 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 333,227 | $486,511 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 23,500 | $475,640 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 3,600 | $389,844 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 192,670 | $225,424 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 62,083 | $139,687 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802630-24-000008 | this filing | 2024-08-14 | acceptance time not in the bulk data set |